SynthesisActa neurologica Scandinavica2016
Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants.
Synthesis in Acta neurologica Scandinavica, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed.
- Progressive Supranuclear Palsy-Primary Lateral Sclerosis Overlap Syndrome in a Patient with aBalkan journal of medical genetics : BJMG · 2026Article
- Peripheral and central inflammation in progressive supranuclear palsy syndrome: an immunological and imaging neuroinflammation study.Frontiers in immunology · 2026Article
- Difficult to Treat Catatonia: A Case Series.Indian journal of psychological medicine · 2025Article
- Celebrating neuropathology's contributions to Alzheimer's Disease Research Centers.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025Article
- Prediagnostic Phase of Progressive Supranuclear Palsy in a Longitudinal Epidemiological Study of Dementia and Aging.Internal medicine (Tokyo, Japan) · 2025Article
- Fast-spiking parvalbumin-positive interneurons: new perspectives of treatment and future challenges in dementia.Molecular psychiatry · 2025Review
- Quality of life in patients with progressive supranuclear palsy: a review of literature and implications for practice.Frontiers in neurology · 2024Review
- Sex differences for cognitive decline in progressive supranuclear palsy.Parkinsonism & related disorders · 2023Article
- Training high level balance and stepping responses in atypical progressive supranuclear palsy: a case report.Physiotherapy theory and practice · 2023Article
- PDQ-8: A Simplified and Effective Tool Measuring Life Quality in Progressive Supranuclear Palsy.Journal of Parkinson's disease · 2023Article
- Clinical outcomes and cognitive impairments between progressive supranuclear palsy and multiple system atrophy.Brain and behavior · 2022Article
- Disease modification in Parkinsonism: obstacles and ways forward.Journal of neural transmission (Vienna, Austria : 1996) · 2022Review
- Striatal dopaminergic lesions contributed to the disease severity in progressive supranuclear palsy.Frontiers in aging neuroscience · 2022Article
- "Parkinson's disease" on the way to progressive supranuclear palsy: a review on PSP-parkinsonism.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021Review
- Article
- Language impairment in progressive supranuclear palsy and corticobasal syndrome.Journal of neurology · 2021Review
- Phenotypic Variants of Patients with Progressive Supranuclear Palsy.Noro psikiyatri arsivi · 2020Article
- Progressive Supranuclear Palsy with Predominant Cerebellar Ataxia.Journal of movement disorders · 2020Article
- Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.BMC neurology · 2019Article
- Frontrunner in Translation: Progressive Supranuclear Palsy.Frontiers in neurology · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Phenotypic heterogeneity of progressive supranuclear palsy (PSP) has been increasingly reported in the literature and can be the source of incorrect clinical diagnosis particularly in the early stages of the disease when the classically associated symptoms of early falls and supranuclear gaze palsy may not be apparent. In addition to Richardson syndrome (RS), several atypical clinical phenotypes have been described. Advances in genetic, neuroimaging, and biochemical/molecular technologies contribute to the identification of these clinical subtypes in the context of typical PSP pathological findings. Our goal is to review the phenomenology reported in the literature that is associated with confirmed histopathological changes consistent with a PSP diagnosis and to highlight the clinical spectrum of PSP. A systematic review of the literature in PubMed through July 2015 using MeSH terms and key words related to PSP was conducted. Articles describing PSP classifications, diagnostic criteria, and case reports were reviewed and summarized. Additional PSP phenotypes not seen in recent clinicopathological studies are included. These include primary lateral sclerosis, pallido-nigro-luysian degeneration, axonal dystrophy, and multiple system atrophy in the spectrum of atypical PSP variants beyond the traditionally classified PSP subtypes. This review is intended to help with the diagnostic challenges of atypical PSP variants. We believe that large multicenter clinicopathological studies will help expand our understanding of etiology and specific mechanisms of neurodegeneration and will aid in the appropriate interpretation of outcomes when conducting clinical and basic science research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.